Abstract
Favorable Outcomes for Patients Treated with U2 with Co-Morbidities or Concomitant Medications: A Retrospective Analysis of Unity-CLL Phase 3 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have